کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2141634 1088293 2012 5 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی تحقیقات سرطان
پیش نمایش صفحه اول مقاله
Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer
چکیده انگلیسی

BackgroundTo investigate the prognostic importance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer (NSCLC).Patients and methodsUsing a prospective design, 118 consecutive participants with histologically confirmed metastatic (inoperable) NSCLC and Eastern Cooperative Oncology group (ECOG) 0–3 completed a six-minute walk test to assess functional capacity and questionnaire that assessed self-reported exercise behavior. Cox proportional models were used to estimate the risk of all-cause mortality according to six-minute walk distance (6MWD) (<358.5 m, 358.5–450 m, ≥450 m) and exercise behavior (MET-hrs wk−1) categories with adjustment for important covariates.ResultsMedian follow-up was 26.6 months; 77 deaths were reported during this period. Functional capacity was an independent predictor of survival (Ptrend = 0.003) and added incremental prognostic value beyond that provided by PS plus other traditional markers of prognosis (Ptrend = 0.025). Compared with patients achieving a 6MWD <358.5 m, the adjusted hazard ratio (HR) for all-cause mortality was 0.61 (95% CI, 0.34–1.07) for a 6MWD of 358.5–450 m, and 0.48 (95% CI, 0.24–0.93) for a 6MWD >450 m. In unadjusted analysis, there was a borderline significant effect of exercise behavior on survival (p = 0.052). Median survival was 12.89 months (95% CI, 9.11–21.05 months) for those reporting <9 MET-hrs wk−1 compared with 25.63 months (95% CI, 11.28 to ∞ months) for those reporting ≥9 MET-hrs wk−1.ConclusionsFunctional capacity is a strong independent predictor of survival in advanced NSCLC that adds to the prediction of survival beyond traditional risk factors. This parameter may improve risk stratification and prognostication in NSCLC.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Lung Cancer - Volume 76, Issue 2, May 2012, Pages 248–252
نویسندگان
, , , , , , , , , , , , ,